{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:38:01Z","timestamp":1710376681078},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[1993,2,1]],"date-time":"1993-02-01T00:00:00Z","timestamp":728524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Ciba-Geigy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1993,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Intravenous disodium 3-amino-1-hydroxypropylidene-1,1-bisphosphonate pentahydrate (pamidronate disodium) was used to treat 39 patients (22 males and 17 females, age range 48\u201385 years) with symptomatic Paget's disease. Patients were stratified into three groups based on the biochemical severity of the disease as assessed by fasting urinary hydroxyproline excretion (HypE, \u03bcmol\/liter GF, glomerular filtrate): group I (n = 23), HypE &amp;lt; 5.0, treated with 120 mg total dose over 2 or 4 days; group II (n = 6), 5.0 \u2264 HypE \u2264 10.0, 180 mg over 3 or 6 days; and group III (n = 10), HypE &amp;gt; 10.0, 240 mg over 4 or 8 days. Bone mineral density (BMD) was measured before and 3 and 6 months following treatment in the spine (LI-4) using dual-energy x-ray absorptiometry and in the forearm at an ultradistal and a shaft site using single-photon absorptiometry. When groups I-III were combined, nonpagetic and pagetic lumbar spinal BMD had both risen significantly at 3 months compared with the pretreatment values (p &amp;lt; 0.001). In each group, lumbar spinal BMD in pagetic vertebrae rose markedly by 3 months, with no further significant change at 6 months. The percentage rises in the three groups were not different from each other at 3 or 6 months. Nonpagetic lumbar spinal BMD followed a similar and significant trend but with a significantly smaller rise than for pagetic bone. (For the combined groups, nonpagetic BMD rose 5.1 \u00b1 1.1% SEM, above pretreatment at 6 months; pagetic BMD rose 17.8 \u00b1 1.6%: significance of comparison = p &amp;lt; 0.0001). In contrast, forearm BMD in group III had fallen at 6 months by 8.3 \u00b1 2.5% (p &amp;lt; 0.01) and 7.0 \u00b1 1.2% (p &amp;lt; 0.001) in the ultradistal and shaft sites, respectively. There were no significant changes in forearm BMD in groups I and II. When groups I-III were combined, the maximum observed changes within each individual in ultradistal forearm BMD (seen posttreatment) were correlated inversely with maximum intraindividual changes (seen posttreatment) in intact parathyroid hormone (Spearman's Q = \u22120.53, p &amp;lt; 0.001). A group of 18 control subjects with untreated Paget's disease were studied for 3\u20136 months. No changes were seen in nonpagetic or pagetic lumbar spinal BMD or in forearm BMD. Three mechanisms are proposed to explain these findings: (1) in nonpagetic bone, persistence of bone formation following acute reduction in resorption, with a more marked effect in the axial than in the appendicular skeleton; (2) in pagetic bone, magnification of mechanism 1, caused by the presence of abnormally active osteoclasts, leading to a marked divergence between bone resorption and formation, and (3) in cancellous and cortical distal forearm bone, the onset of acute secondary hyperparathyroidism following treatment, leading to resorption. These findings have implications for treatment of Paget's disease using pamidronate or other bisphosphonates in patients with preexisting appendicular osteopenia, particularly if the treatment-induced appendicular deficit is sustained.<\/jats:p>","DOI":"10.1002\/jbmr.5650080212","type":"journal-article","created":{"date-parts":[[2010,2,3]],"date-time":"2010-02-03T16:46:30Z","timestamp":1265215590000},"page":"209-217","source":"Crossref","is-referenced-by-count":16,"title":["Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of paget's disease with pamidronate disodium"],"prefix":"10.1093","volume":"8","author":[{"given":"Roger I.","family":"Price","sequence":"first","affiliation":[{"name":"Department of Biophysics, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"},{"name":"Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald H.","family":"Gutteridge","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwyn G.A.","family":"Stuckey","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Neil","family":"Kent","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Retallack","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard L.","family":"Prince","sequence":"additional","affiliation":[{"name":"University Department of Medicine, University of Western Australia, Sir Charles Gairdner Hospital, Nedlands, Australia"},{"name":"Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chotoo I.","family":"Bhagat","sequence":"additional","affiliation":[{"name":"State Health Laboratories, Perth, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine A.","family":"Johnston","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey C.","family":"Nicholson","sequence":"additional","affiliation":[{"name":"University Department of Medicine, University of Melbourne, Geelong Hosptial, Geelong, Victoria, Australia"},{"name":"University Department of Medicine, University of Western Australia, Fremantle Hospital, Fremantle, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme O.","family":"Stewart","sequence":"additional","affiliation":[{"name":"University Department of Medicine, University of Western Australia, Fremantle Hospital, Fremantle, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1993,2,1]]},"reference":[{"key":"2024013113121216900_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00003086-198704000-00010","article-title":"Efficacious management with aminobis-phosphonate (APD) in Paget's disease of bone","volume":"217","author":"Harinck","year":"1987","journal-title":"Clin Orthop"},{"key":"2024013113121216900_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2265.1991.tb00294.x","article-title":"Intravenous aminobisphos-phonate in Paget's disease: Clinical, biochemical, histomorphometric and radiological responses","volume":"34","author":"Fenton","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024013113121216900_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00003086-198704000-00009","article-title":"Experimental basis for the use of bisphosphonates in Paget's disease of bone","volume":"217","author":"Fleisch","year":"1987","journal-title":"Clin Orthop"},{"key":"2024013113121216900_bib4","first-page":"227","article-title":"Treatment of osteoporoses by manipulation of coherent bone cell populations","volume":"143","author":"Frost","year":"1979","journal-title":"Clin Orthop"},{"key":"2024013113121216900_bib5","first-page":"1507","volume-title":"Osteoporosis 1990","author":"Devogelaer","year":"1990"},{"key":"2024013113121216900_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0169-6009(89)90095-0","article-title":"Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD","volume":"5","author":"Valkema","year":"1989","journal-title":"Bone Miner"},{"key":"2024013113121216900_bib7","first-page":"1504","volume-title":"Osteoporosis 1990","author":"Devogelaer","year":"1990"},{"key":"2024013113121216900_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01625440","article-title":"Differential action of pamidronate on trabecular and cortical bone in women with involutional osteoporosis","volume":"1","author":"Fromm","year":"1991","journal-title":"Osteoporosis Int"},{"key":"2024013113121216900_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(88)92721-3","article-title":"Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)","volume":"1","author":"Reid","year":"1988","journal-title":"Lancet"},{"key":"2024013113121216900_bib10","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1136\/bmj.286.6378.1648","article-title":"Non-hormonal treatment of osteoporosis (letter)","volume":"286","author":"de Deuxchaisnes","year":"1983","journal-title":"Br Med J"},{"key":"2024013113121216900_bib11","first-page":"1451","volume-title":"Osteoporosis 1990","author":"Geusens","year":"1990"},{"key":"2024013113121216900_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0003-2697(67)90160-1","article-title":"Modifications of the specific assay for hydroxyproline in urine","volume":"19","author":"Kivirikko","year":"1967","journal-title":"Anal Biochem"},{"key":"2024013113121216900_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0009-8981(88)90227-6","article-title":"Comparison of the performance and clinical utility of a carboxy-terminal assay and an intact assay for parathyroid hormone","volume":"178","author":"St John","year":"1988","journal-title":"Clin Chim Acta"},{"key":"2024013113121216900_bib14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1210\/jcem-67-4-839","article-title":"Quantitative digital radiography versus dual photon absorptiometry of the lumbar spine","volume":"67","author":"Kelly","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013113121216900_bib15","article-title":"Dual-energy digital x-ray densitometry in the determination of mineralisation of the spine and hip: Reproducibility studies and strategies for optimal scans of trabecular bone","volume":"32","author":"Price","year":"1989","journal-title":"Proc Endocrinol Soc Aust"},{"key":"2024013113121216900_bib16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jbmr.5650040204","article-title":"Ultradistal and cortical forearm beon density in the assessment of postmenopausal bone loss and non-axial fracture risk","volume":"4","author":"Price","year":"1989","journal-title":"J Bone Miner Res"},{"key":"2024013113121216900_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF02546396","article-title":"The distribution of cortical and trabecular bone mass along the lengths of the radius and ulna and the implications for in-vivo bone measurements","volume":"20","author":"Schlenker","year":"1976","journal-title":"Calcif Tissue Res"},{"key":"2024013113121216900_bib18","first-page":"204","volume-title":"Data Reduction and Error Analysis for the Physical Sciences","author":"Bevington","year":"1969"},{"key":"2024013113121216900_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2265.1990.tb00892.x","article-title":"Treatment of Paget's disease of bone","volume":"32","author":"Cantrill","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024013113121216900_bib20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jbmr.5650050611","article-title":"Prevention of glucocorticoid-induced osteoporosis","volume":"5","author":"Reid","year":"1990","journal-title":"J Bone Miner Res"},{"key":"2024013113121216900_bib21","first-page":"315","volume-title":"Atlas of Orthopaedic Pathology","author":"Bullough","year":"1984"},{"key":"2024013113121216900_bib22","first-page":"69","article-title":"Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD","volume":"1","author":"Papapoulous","year":"1986","journal-title":"Bone Miner"},{"key":"2024013113121216900_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0889-8529(18)30337-2","article-title":"Bone disease in primary hyperparathyroidism","volume":"19","author":"Parisien","year":"1990","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2024013113121216900_bib24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/bmj.290.6461.64","article-title":"Long term follow up of untreated primary hyperparathyroidism","volume":"290","author":"de Deuxchaisnes","year":"1985","journal-title":"Br Med J"},{"key":"2024013113121216900_bib25","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archinte.1990.00390180133024","article-title":"Relationship between forearm and vertebral mineral density in postmenopausal women with primary hyperparathyroidism","volume":"150","author":"Wishart","year":"1990","journal-title":"Arch Intern Med"},{"key":"2024013113121216900_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"key":"2024013113121216900_bib27","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/bmj.280.6228.1340","article-title":"Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: A multicentre trial","volume":"280","author":"Reeve","year":"1980","journal-title":"Br Med J"},{"key":"2024013113121216900_bib28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jbmr.5650010411","article-title":"Restoration of spinal bone in osteporotic men by treatment with human parathyroid hormone (1\u201334) and 1,25-dihydroxyvitamin D","volume":"1","author":"Slovik","year":"1986","journal-title":"J Bone Miner Res"},{"key":"2024013113121216900_bib29","first-page":"119","volume-title":"Calcium Regulation and Bone Metabolism: Basic and Clinical Aspects","author":"Slovik","year":"1987"},{"key":"2024013113121216900_bib30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-70-4-930","article-title":"The histomorphometry of bone in primary hyperparathyroidism: Preservation of cancellous bone structure","volume":"70","author":"Parisien","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013113121216900_bib31","first-page":"301","article-title":"Trabecular and cortical bone in the radii of women with parathyroid adenomata: A greater trabecular deficit with a preliminary assessment of recovery after parathyroidectomy","volume":"2","author":"Hesp","year":"1987","journal-title":"Bone Miner"},{"key":"2024013113121216900_bib32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(79)91318-7","article-title":"Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)","volume":"1","author":"Frijlink","year":"1979","journal-title":"Lancet"},{"key":"2024013113121216900_bib33","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/jcem-54-4-837","article-title":"Long term effects of dichloromethylene diphosphonate in Paget's disease of bone","volume":"54","author":"Delmas","year":"1982","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.5650080212","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/8\/2\/209\/56491770\/5650080212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/8\/2\/209\/56491770\/5650080212.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:55:33Z","timestamp":1710341733000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/8\/2\/209-217\/7500508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,2,1]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[1993,2,1]]},"published-print":{"date-parts":[[1993,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.5650080212","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1993,2,1]]},"published":{"date-parts":[[1993,2,1]]}}}